http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190066491-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_990775f1d7d9cb35dee0bb53648c8b7b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate | 2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86482156d1c8eaa93ca2270a7e546f0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4895a065d2c816c772fb80440bffbc1d |
| publicationDate | 2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190066491-A |
| titleOfInvention | Pharmaceutical composition comprising the extracts from the flesh and seed of passion fruit as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
| abstract | The present invention relates to an antithrombotic composition containing a mixed extract of Passiflor ( Passiflora edulis ) pulp and seed as an active ingredient, and more particularly, to an antithrombotic composition comprising an extract of ethanol from a mixture of flesh and seed of a washed, And to a pharmaceutical composition and a health functional food for preventing or treating / improving thrombosis through inhibition of blood clotting containing the same as an effective ingredient. The pharmaceutical composition for the prevention or treatment of thrombosis according to the present invention and the mixed extract of the fashionable fruit pulp and seed as an active ingredient of the health functional food can be used for the prevention and treatment of thrombogenesis-related enzyme inhibition and blood coagulation And exhibits a strong antithrombotic activity due to the inhibition of factors and exhibits no hemolytic activity against human erythrocytes and exhibits excellent thermal stability and can be used in an acidic condition of pH 2 and in a blood plasma for inhibiting thrombogenic enzymes and blood coagulation factors It is expected that it can be used for prevention and treatment of thrombosis such as ischemic stroke and hemorrhagic stroke through improvement of blood circulation and the active ingredient is processed into various forms such as extract, powder, ring, tablet, etc., Because it has excellent effect that can be prepared in this possible form, Eopsang is a very useful invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020246660-A1 |
| priorityDate | 2017-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.